Hui-Chuan Sun (Huichuan Sun)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 8

Top Topics

Metastatic Colorectal Cancer

Top Venues

Cancer immunology, immunotherapy : CII

Surgical innovation

Biomarker research

This page only lists publications with an associated author ORCID identifier.

Publications

Ming-Hao Xu, Cheng Huang, Mei-Ling Li, Xiao-Dong Zhu, Chang-Jun Tan, Jian Zhou, Jia Fan, Hui-Chuan Sun, Ying-Hao Shen
Effectiveness and safety of lenvatinib plus anti-programmed death-1 antibodies in patients with hepatocellular carcinoma: A real-world cohort study. Cancer medicine (2023)
Nan Xiao, Kangshuai Li, Xiaodong Zhu, Bin Xu, Xuefeng Liu, Ming Lei, Hui-Chuan Sun
CD74+ macrophages are associated with favorable prognosis and immune contexture in hepatocellular carcinoma. Cancer immunology, immunotherapy : CII (2021)
Nan Xiao, Xiao-Long Li, Xiao-Dong Zhu, Cheng Huang, Ying-Hao Shen, Jian Zhou, Jia Fan, Hui-Chuan Sun
Increase of Portal Vein Pressure Gradient After Hepatectomy Predicts Post-operative Liver Dysfunction. Surgical innovation (2021)
Jian-Ming Xu, Yuxian Bai, Hui-Chuan Sun, Chun-Mei Bai, Ru Jia, Yi Li, Wenjie Zhang, Lei Liu, Cheng Huang, Mei Guan, Jinghong Zhou, Weiguo Su
A single-arm, multicenter, open-label phase 2 trial of surufatinib in patients with unresectable or metastatic biliary tract cancer. Cancer 127 (21) (2021)
Cheng Huang, Xiao-Dong Zhu, Ying-Hao Shen, Dong Wu, Yuan Ji, Ning-Ling Ge, Ling-Li Chen, Chang-Jun Tan, Jian Zhou, Jia Fan, Hui-Chuan Sun
Organ specific responses to first-line lenvatinib plus anti-PD-1 antibodies in patients with unresectable hepatocellular carcinoma: a retrospective analysis. Biomarker research 9 (1) (2021)
Bin Xu, Xiao-Long Li, Feng Ye, Xiao-Dong Zhu, Ying-Hao Shen, Cheng Huang, Jian Zhou, Jia Fan, Yong-Jun Chen, Hui-Chuan Sun
Development and Validation of a Nomogram Based on Perioperative Factors to Predict Post-hepatectomy Liver Failure. Journal of clinical and translational hepatology 9 (3) (2021)
Nan Xiao, Xiaodong Zhu, Kangshuai Li, Yifan Chen, Xuefeng Liu, Bin Xu, Ming Lei, Jiejie Xu, Hui-Chuan Sun
Blocking siglec-10hi tumor-associated macrophages improves anti-tumor immunity and enhances immunotherapy for hepatocellular carcinoma. Experimental hematology & oncology 10 (1) (2021)
Xiao-Dong Zhu, Hui-Chuan Sun
Emerging agents and regimens for hepatocellular carcinoma. Journal of hematology & oncology 12 (1) (2019)